Characterization of glycopeptide resistant enterococci isolated from a hospital in Naples (Italy)

New Microbiologica

Volumn 28, Issue 2, 2005, Pages 171-176

  Galdiero, Emilia ^a   Villari, Paolo ^b   Di Onofrio, Valeria ^c   Pisciotta, Maria Grazia ^d   Lucariello, Angela ^c   Sommese, Linda ^d   Liguori, Giorgio ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Antibiotic resistance; Enterococcus spp.; Genotype; Glycopeptides; Phenotype; Vancomycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; NORFLOXACIN; PENICILLIN G; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; ITALY; MOLECULAR TYPING; NONHUMAN; PHENOTYPE; RANDOM AMPLIFIED POLYMORPHIC DNA; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GENOTYPE; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; ITALY; MICROBIAL SENSITIVITY TESTS; PHENOTYPE;

ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE;

EID: 21244485056     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. AKOPYANZ, N., BUKANOV, N.O., WESTBLOM, T.U., KRESOVICH, S., BERG, D.E. (1992). DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Research, 20, 5137-5142.
2. ANDRIGHETTO, C., KNIJFF, E., LOMBARDI, A., TORRIANI, S., VANCANNEYT, M., KERSTERS, K., SWINGS, J., DELLAGLIO, F. (2001). Phenotypic and genetic diversity of enterococci isolated from Italian cheeses. Journal of Dairy Research, 68, 303-316.
3. BARBIER, N., SAULNIER, P., CHACHATY, E., DUMONTIER, S., ANDREMONT, A. (1996). Random amplified polymorphic DNA typing versus pulsed-field gel electrophoresis for epidemiological typing of vancomycin-resistant enterococci. Journal of Clinical Microbiology, 34, 1096-1099.
4. BELL, J.M., PATON, J.C., TURNIDGE, J. (1998). Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. Journal of Clinical Microbiology 36, 2187-2190.
5. BIODISK A.B. (1995). E-test technical guide 3B. AB Biodisk, Solna, Sweden.
6. CAMPANILE, F., BARTOLINI, A., BARTALESI, F., BORBONE, S., MANGANI, V., MANTELLA, A., NICOLETTI, G., PARADISI, F., RUSSO, G., STROHMEYER, M., STEFANI, S. (2003). Molecular alterations of VanA element in vancomycin-resistent enterococci isolated during a survey of colonized patients in Italian intensive care unit. Microbial Drug Resistance Mechanisms Epidemiology and Disease, 9, 191-199.
7. CHENOWETH, C., SCHABERG, D. (1990). The epidemiology of enterococci. European Journal of Clinical Microbiology & Infectiuus Diseases, 9, 80-89.
8. DUTKA-MALEN, S., EVERS, S., COURVALIN, P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. Journal of Clinical Microbiology, 33, 24-27.
9. EOM, J.S., HWANG, I.S., HWANG, B.Y., LEE, J.G., LEE, Y.J., CHEONG, H.J., PARK, Y.H., PARK, S.C., KIM, W.J. (2004). Emergence of vanA genotype vancomycin-resistant Enterococci with low or moderate levels of teicoplanin resistance in Korea. Journal of Clinical Microbiology, 42, 1785-1786.
10. FINES, M., PERICHON, B., REYNOLDS, P., SAHM, D.F., COURVALIN, P. (1999). VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrobial Agents and Chemotherapy, 43, 2161-2164.
11. FRIDKIN, S.K., YOKOE, D.S., WHITNEY, C.G., ONDERDONK, A., HOOPER, D.C. (1998). Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusettes. Journal of Clinical Microbiology, 36, 965-970.
12. HANDWERGER, S., SKOBLE, J. (1995) Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrobial Agents and Chemotherapy, 39, 2446-2453.
13. HASHIMOTO, Y., TANIMOTO, K., OZAWA, Y., MURATA, T., IKE, Y. (2000). Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance. FEMS Microbiology Letter 15; 185, 247-254.
14. HUEY, B., HALL, J. (1989). Hypervariable DNA finger-printing in Eschenchia coli. Minisatellite probe from bacteriophage M13. Journal of Bacteriology, 171, 2528-2532.
15. LAUDERDALE, T.L., MCDONALD, L.C., SHIAU, Y.R., CHEN, P.C., WANG, H.Y., LAI, J.F., Ho, M. (2000). Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrobial Agents and Chemotherapy, 46, 525-527.
16. LECLERCQ, R., DERLOT, E., DUVAL, J., COURVALIN, P. (1988). Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New England Journal of Medicine, 319, 157-161.
17. LIASSINE, N., FREI, R., JAN, I., AUCKENTHALER, R. (1998). Characterization of glycopeptide-resistant Enterococci from a Swiss hospital. Journal of Clinical Microbiology, 36, 1853-1858.
18. MOELLERING R.C. Jr. (1992). Emergence of Enterococcus as a significant pathogen. Clinical Infectious Diseases, 14, 1173-1176.
19. MURRAY B.E. (1998). Diversity among multidrug-resistant enterococci. Emerging Infectious Diseases, 4, 37-47.
20. NCCLS. (1999). Performance standards for antimicrobial susceptibility testing. Ninth informal supplement, vol. 19. NCCLS, Wayne, Pa.
21. OSTROWSKY, B.E., CLARK, N.C., THAUVIN-ELIOPOULOS, C., VENKATARAMAN, L., SAMORE, M.H., TENOVER, F.C., ELIOPOULOS, G.M., MOELLERING, R.C. JR, GOLD, H.S. (1999). A cluster of VanD vancomycin-resistant Enterococcus faecium: molecular characterization and clinical epidemiology. The Journal of Infections Disease, 180, 1177-1185.
22. WOODFORD, N., ADEBIYI, A.M., PALEPOU, M.F., COOKSON, B.D. (1998). Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhumans sources. Antimicrobial Agents and Chemotherapy, 42, 502-508.